pentoxifylline has been researched along with Cancer of Prostate in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Of 30 patients with radiation-induced proctitis/enteritis grade I-II according to the RTOG/EORTC toxicity criteria, 21 were treated with pentoxifylline and tocopherol." | 7.73 | Effect of pentoxifylline and tocopherol on radiation proctitis/enteritis. ( Christiansen, H; Hermann, RM; Hess, CF; Hilgers, R; Hille, A; Pradier, O; Schmidberger, H; Siekmeyer, B; Weiss, E, 2005) |
| "Of 30 patients with radiation-induced proctitis/enteritis grade I-II according to the RTOG/EORTC toxicity criteria, 21 were treated with pentoxifylline and tocopherol." | 3.73 | Effect of pentoxifylline and tocopherol on radiation proctitis/enteritis. ( Christiansen, H; Hermann, RM; Hess, CF; Hilgers, R; Hille, A; Pradier, O; Schmidberger, H; Siekmeyer, B; Weiss, E, 2005) |
| "We study whether the PTX sensitizes prostate cancer cells to DTX for greater effectiveness." | 1.62 | Sensitizing the cytotoxic action of Docetaxel induced by Pentoxifylline in a PC3 prostate cancer cell line. ( Bravo-Cuellar, A; Cancino-Marentes, ME; Cruz-Gálvez, CC; Hernández-Flores, G; Orozco-Alonso, E; Ortiz-Lazareno, PC; Sierra-Díaz, E; Solís-Martínez, RA; Villaseñor-García, MM, 2021) |
| " Treatment comprised removal of loose necrotic bone sequestrae, debridement of the fistulae and long-term administration of antibiotics, vitamin E and pentoxifylline." | 1.51 | Uncommon presentation of medication-related osteonecrosis of the mandible in a patient with metastatic prostate cancer. ( Jayaram, R; Thavarajah, M, 2019) |
| "The sensitisation of prostate cancer cells to cytotoxic drugs is particularly high in radiation-resistant TP53 mutant tumour cells." | 1.31 | Chemosensitivity of prostatic tumour cell lines under conditions of G2 block abrogation. ( Binder, AB; Böhm, L; Serafin, AM, 2001) |
| "The standard therapy for advanced prostate cancer is androgen ablation." | 1.28 | Cyclic AMP induces transforming growth factor beta 2 gene expression and growth arrest in the human androgen-independent prostate carcinoma cell line PC-3. ( Bang, YJ; Danielpour, D; Kim, KY; Kim, SJ; Myers, CE; O'Reilly, MA; Trepel, JB, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cancino-Marentes, ME | 1 |
| Hernández-Flores, G | 1 |
| Ortiz-Lazareno, PC | 1 |
| Villaseñor-García, MM | 1 |
| Orozco-Alonso, E | 1 |
| Sierra-Díaz, E | 1 |
| Solís-Martínez, RA | 1 |
| Cruz-Gálvez, CC | 1 |
| Bravo-Cuellar, A | 1 |
| Thavarajah, M | 1 |
| Jayaram, R | 1 |
| Hille, A | 1 |
| Christiansen, H | 1 |
| Pradier, O | 1 |
| Hermann, RM | 1 |
| Siekmeyer, B | 1 |
| Weiss, E | 1 |
| Hilgers, R | 1 |
| Hess, CF | 1 |
| Schmidberger, H | 1 |
| Joseph, IB | 1 |
| Isaacs, JT | 1 |
| Serafin, AM | 1 |
| Binder, AB | 1 |
| Böhm, L | 1 |
| Bang, YJ | 1 |
| Kim, SJ | 1 |
| Danielpour, D | 1 |
| O'Reilly, MA | 1 |
| Kim, KY | 1 |
| Myers, CE | 1 |
| Trepel, JB | 1 |
6 other studies available for pentoxifylline and Cancer of Prostate
| Article | Year |
|---|---|
Sensitizing the cytotoxic action of Docetaxel induced by Pentoxifylline in a PC3 prostate cancer cell line.
Topics: Antineoplastic Agents; Docetaxel; Humans; Male; PC-3 Cells; Pentoxifylline; Phosphodiesterase Inhibi | 2021 |
Uncommon presentation of medication-related osteonecrosis of the mandible in a patient with metastatic prostate cancer.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Bone Density Conservation Agents; Free Radical Scavengers; | 2019 |
Effect of pentoxifylline and tocopherol on radiation proctitis/enteritis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antioxidants; Chi-Square Distribution; Data In | 2005 |
Macrophage role in the anti-prostate cancer response to one class of antiangiogenic agents.
Topics: Animals; Antineoplastic Agents; Enzyme-Linked Immunosorbent Assay; Genistein; Granulocyte-Macrophage | 1998 |
Chemosensitivity of prostatic tumour cell lines under conditions of G2 block abrogation.
Topics: Drug Screening Assays, Antitumor; G2 Phase; Humans; Male; Pentoxifylline; Prostatic Neoplasms; Tumor | 2001 |
Cyclic AMP induces transforming growth factor beta 2 gene expression and growth arrest in the human androgen-independent prostate carcinoma cell line PC-3.
Topics: 1-Methyl-3-isobutylxanthine; Aprotinin; Blotting, Northern; Bucladesine; Cell Division; Cell Line; C | 1992 |